Msd Polska

What Msd Polska does

MSD Polska Sp. z o.o. is the Polish operating subsidiary of Merck & Co., Inc. (NYSE: MRK), known globally as MSD outside the United States and Canada. Established in Poland in 1991, the company develops and supplies innovative human medicines and vaccines with therapeutic emphasis on oncology, immuno-oncology, novel vaccine development, and antibiotic research targeting antibiotic-resistant bacteria. It also operates the MSD Animal Health line for veterinary pharmaceuticals in Poland. Headquartered in Warsaw at Ul. Chłodna 51, MSD Polska employs approximately 800 people as of December 2025.

The company runs an integrated operating stack that includes a wholly-owned distribution subsidiary, MSD Dystrybucja Sp. z o.o., and dedicated digital platforms such as msddlalekarzy.pl for physicians and hpv.pl for patient HPV vaccination education. MSD Polska conducts clinical research and data management in Poland and operates the Warsaw Health Innovation Hub, an innovation and talent initiative that includes the MedConnect internship program in partnership with the University of Warsaw, the Medical Research Agency (Agencja Badań Medycznych), and Polish pharmaceutical universities.

Commercially, MSD Polska pursues an enterprise field sales motion targeting hospitals, clinics, pharmacies, and healthcare institutions via medical representatives, supplemented by webinars, email, and professional portals. The company adheres to the INFARMA Good Practices Code and has been recognized with the Etyczna Firma (2025, 2026) and Orzeł Zdrowia (2025) awards. As a wholly-owned subsidiary of a publicly traded parent, standalone Polish revenue is not disclosed; capital allocation, R&D, and product strategy flow from Merck & Co. headquarters in Rahway, New Jersey.

Name

Msd Polska

Legal name

MSD Polska Sp. z o.o.

Website

https://msd.pl

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Prescription Pharmaceuticals

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Scientific Research and Development Services (5417)

SIC

Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Vaccine Clinical Development & Regulatory Affairs (HLAIAEAM)

akta.pro secondary industries

Veterinary Vaccines (Biologics) (HLAMAEAL), Veterinary Vaccines (HLAIAEAH), Clinical Development & Regulatory for Vaccines (trials, pharmacovigilance, lot release) (HLAAAEAK)

Keywords

• Prescription pharmaceuticals
• Vaccine development
• Animal health products
• Clinical research services
• Biopharmaceutical medicines

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Pharmaceutical Products: Sale of prescription pharmaceutical products including innovative medicines for oncology, vaccines, and other therapeutic areas. The company invests more than one-quarter of global turnover in R&D.
2. Vaccines: Development and sale of vaccines for human health.
3. Animal Health Products: MSD Animal Health division provides veterinary pharmaceutical products.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

MSD Polska develops, supplies, and distributes prescription human pharmaceuticals and vaccines covering therapeutic areas including oncology, vaccines, and infectious diseases, alongside a separate MSD Animal Health line of veterinary pharmaceutical products. The subsidiary also conducts clinical research and data management activities within Poland, drawing on the parent Merck & Co., Inc.'s global biopharmaceutical R&D platform.

Product overview

MSD Polska is a biopharmaceutical company operating as part of the global Merck & Co. conglomerate (known as MSD outside the US and Canada). The company offers a portfolio of innovative medicines and vaccines for human health, alongside MSD Animal Health for veterinary pharmaceuticals. The organizational structure includes MSD Polska Sp. z o.o. (core pharmaceutical operations) and MSD Polska Dystrybucja Sp. z o.o. (distribution subsidiary). The company also operates specialized digital platforms including msddlalekarzy.pl (for physicians) and hpv.pl (patient education), with additional initiatives like the MedConnect internship program conducted through Warsaw Health Innovation Hub.

Differentiator

Problem solved

Functional benefit

Brands

• MSD Animal Health: Animal health division of MSD operating in Poland
• MSD for Mothers
• MSD Dystrybucja
• Warsaw Health Innovation Hub

Products and services

• MSD Polska Human Health prescription pharmaceuticals Innovative human medicines and vaccines covering therapeutic areas including oncology, vaccines, and infectious diseases, supplied to hospitals, clinics, and pharmacies in Poland through MSD Polska's sales force and distribution subsidiary.
• MSD Animal Health veterinary pharmaceuticals Veterinary pharmaceutical products offered to veterinarians and animal health providers in Poland under the MSD Animal Health brand.
• Clinical research and data management services Biopharmaceutical clinical trial operations and data management conducted in Poland, supporting the parent group's R&D pipeline across oncology, vaccines, and antibiotics.
• MSD Dystrybucja pharmaceutical wholesale distribution Wholesale distribution of MSD Polska's branded prescription pharmaceutical products to pharmacies, hospitals, and other healthcare customers across Poland, operated through the dedicated subsidiary MSD Dystrybucja Sp. z o.o.

Quantifiable outcome

• Over 130 years contributing to medical progress

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Uniwersytet Warszawski (University of Warsaw)coreStrategic or Co-development PartnerCollaboration between University of Warsaw and MSD Polska for public health initiatives. This partnership focuses on joint efforts to advance healthcare in Poland.
• Warsaw Health Innovation HubcoreStrategic or Co-development PartnerMSD Polska organizes programs including the MedConnect internship program under the Warsaw Health Innovation Hub initiative, fostering innovation in healthcare.
• Agencja Badań Medycznych (Medical Research Agency)coreStrategic or Co-development PartnerThe Medical Research Agency provides patronage for the MedConnect internship program. The agency supports the development of future healthcare leaders.
• Polish Pharmaceutical UniversitiescoreStrategic or Co-development PartnerCollaboration with pharmaceutical faculties of Polish universities for the MedConnect internship program. Students from these institutions are selected for internships at MSD Polska.
• INFARMAminorOthersMSD Polska adheres to the Good Practices Code (Kodeks Dobrych Praktyk) published by INFARMA, the Polish employers' association of innovative pharmaceutical industry.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• AbbVie Poland: Polish subsidiary of AbbVie, focused on innovative therapeutics in immunology, oncology, and neuroscience. Comparable to MSD Polska as a multinational pharma subsidiary commercializing innovative specialty medicines in Poland.
• Sanofi Poland: Polish subsidiary of Sanofi. Comparable as a multinational pharma subsidiary operating in vaccines, specialty care, and animal health (through Merial/Boehringer Ingelheim Animal Health) in the Polish market.
• Bayer Poland: Polish subsidiary of Bayer, with both pharmaceutical and animal health (Animal Health) divisions. Comparable to MSD Polska across pharma and animal health product lines and clinical research operations in Poland.
• Johnson & Johnson Poland: Polish subsidiary of J&J, a global pharma and medical devices leader. Comparable to MSD Polska as a peer multinational pharma subsidiary with overlapping therapeutic areas including oncology and immunology in Poland.
• AstraZeneca Poland: Polish subsidiary of AstraZeneca. Comparable to MSD Polska as a multinational pharma subsidiary with strong presence in oncology, vaccines, and respiratory therapies, conducting clinical trials and commercial operations in Poland.
• Roche Polska: Polish subsidiary of Roche, a global leader in oncology and diagnostics. Directly comparable as a multinational pharma subsidiary operating innovative oncology therapies and clinical research in Poland.
• GSK Poland: Polish operations of GSK. Highly comparable given GSK's leadership in vaccines (a core area of MSD Polska) alongside specialty pharmaceuticals, with a similar subsidiary structure handling clinical research and commercial sales in Poland.
• Pfizer Polska: Polish subsidiary of Pfizer, one of the world's largest biopharmaceutical companies. Directly comparable to MSD Polska as a multinational pharma subsidiary operating R&D, clinical trials, and commercial sales across human vaccines, oncology, and other innovative therapies in the Polish market.
• Eli Lilly Poland: Polish subsidiary of Eli Lilly, a global pharmaceutical company with strong oncology and diabetes franchises. Comparable as a peer multinational pharma subsidiary with innovative-medicines focus and clinical research activity in Poland.
• Novartis Poland: Polish operations of Novartis, a global pharmaceutical leader. Comparable to MSD Polska as a peer multinational pharma subsidiary in Poland with overlapping presence in innovative medicines, oncology, and clinical research.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/login/?next=https%3A%2F%2Fwww.facebook.com%2FMSDPolska
• LinkedInlinkedin.com/company/msd-polska-sp-z-o-o

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Msd Polska